Collegium Pharmaceutical, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Collegium Pharmaceutical, Inc. (COLL) had Restricted Cash and Cash Equivalents, Noncurrent of $20.91 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-08-06
- 2026-06-30: Restricted Cash and Cash Equivalents, Noncurrent $20.91M.
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $20.91M.
- 2025-12-31: Restricted Cash and Cash Equivalents, Noncurrent $20.91M.
- 2025-09-30: Restricted Cash and Cash Equivalents, Noncurrent $20.90M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2026-06-30 | $20.91M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $20.91M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $20.91M 10-K · filed 2026-02-26 |
| 2025-09-30 | $20.90M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $20.90M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $20.90M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $26.05M 10-K · filed 2026-02-26 |
| 2024-09-30 | $26.05M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $1.05M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $1.05M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $1.05M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.05M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $1.05M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $2.55M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $2.55M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.55M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $2.55M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $2.55M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $2.55M 10-K · filed 2024-02-22 |
| 2021-09-30 | $2.55M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $2.55M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $2.55M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $2.55M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.55M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $2.55M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $2.65M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
| 2018-03-31 | $703.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $97.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $97.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $97.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $97.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $97.00K 10-K · filed 2018-03-07 |
| 2016-09-30 | $97.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $97.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $97.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $97.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $97.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $97.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $97.00K 10-Q/A · filed 2015-07-17 |
| 2014-12-31 | $80.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |